|
|
|
Volumn 301, Issue 5639, 2003, Pages 1450-1451
|
|
U.S. Biodefense boom: Eight new study centers
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRAX VACCINE;
MONKEYPOX VACCINE;
ORTHOPOXVIRUS VACCINE;
PLAGUE VACCINE;
Q FEVER VACCINE;
SMALLPOX VACCINE;
TULAREMIA VACCINE;
UNCLASSIFIED DRUG;
VACCINE;
VIRUS VACCINE;
ANTHRAX;
BIOLOGICAL WARFARE;
BOTULISM;
DIAGNOSTIC ACCURACY;
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE DELIVERY;
HEALTH CARE QUALITY;
HEALTH CENTER;
HEMORRHAGIC FEVER;
INFECTION;
LABORATORY;
MEDICAL RESEARCH;
MONKEYPOX;
NOTE;
ORTHOPOXVIRUS;
PLAGUE;
PRIORITY JOURNAL;
Q FEVER;
SCIENCE;
SMALLPOX;
TULAREMIA;
UNITED STATES;
VALIDATION PROCESS;
ARTICLE;
ECONOMICS;
HEALTH CARE ORGANIZATION;
UNIVERSITY;
ANTHRAX;
ORTHOPOXVIRUS;
VARIOLA VIRUS;
BIOTERRORISM;
FEDERAL GOVERNMENT;
FINANCING, GOVERNMENT;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RESEARCH SUPPORT;
UNITED STATES;
UNIVERSITIES;
VACCINES;
|
|
EID: 0141574257
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|